CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter on ...

The 1-Wire protocol is usually found in temperature sensors, but you’ll also find it in chips ranging from load sensors, a battery sensor and LED driver that is oddly yet officially called a ...

(1) Fair value changes include gains and losses related to quarterly fair value adjustments of our warrant liability, warrant asset, marketable equity securities, contingent consideration ...

IPS test validation study data will be unveiled at the 2024 SITC Annual Meeting CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc.

Tempus AI, Inc, a healthcare technology company ... listing price), which is double the returns of the Nasdaq, and also 1.77x the return threshold of a diversified portfolio of AI themed stocks.

Tempus priced at the top of its expected $35 to $37 range, raising over $410 million and resulting in a valuation of $6.1 ...

Gifting allows recipients to access the article for free. Tempus AI announced today it is acquiring genetic testing and laboratory service provider Ambry Genetics in a $600 million deal that the ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended September 30, 2024, and provided recent business ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...